Gene · 6833
Papers4,205
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,205
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes? | Int J Mol Sci | 2021 | 34638652 | PubTator, text mining | PubMed |
| Beta-Cell Ion Channels and Their Role in Regulating Insulin Secretion. | Compr Physiol | 2021 | 34636409 | PubTator, text mining | PubMed |
| Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11. | Eur J Endocrinol | 2021 | 34633981 | PubTator, text mining | PubMed |
| Clinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review. | J Diabetes Res | 2021 | 34631896 | PubTator, text mining | PubMed |
| Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment. | Front Oncol | 2021 | 34631510 | PubTator, text mining | PubMed |
| Double paternal uniparental isodisomy 7 and 15 presenting with Beckwith-Wiedemann spectrum features. | Cold Spring Harb Mol Case Stud | 2021 | 34615670 | PubTator, text mining | PubMed |
| The neurogliovascular unit in hepatic encephalopathy. | JHEP Rep | 2021 | 34611619 | PubTator, text mining | PubMed |
| [Clinical features of 123 patients with hyperinsulinemic hypoglycemia auxiliarily diagnosed by 18F-DOPA-PET CT scanning]. | Zhonghua Er Ke Za Zhi | 2021 | 34587682 | PubTator, text mining | PubMed |
| Do second generation sequencing techniques identify documented genetic markers for neonatal diabetes mellitus? | Heliyon | 2021 | 34584998 | PubTator, text mining | PubMed |
| ATAD2 controls chromatin-bound HIRA turnover. | Life Sci Alliance | 2021 | 34580178 | PubTator, text mining | PubMed |
| Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine. | J Pers Med | 2021 | 34575672 | PubTator, text mining | PubMed |
| Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer. | Pharmaceutics | 2021 | 34575583 | PubTator, text mining | PubMed |
| Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K+ Channels: Role in the Adverse Drug Reactions. | Pharmaceutics | 2021 | 34575427 | PubTator, text mining | PubMed |
| Is Gestational Diabetes Mellitus a Risk Factor of Maternal Breast Cancer? A Systematic Review of the Literature. | Biomedicines | 2021 | 34572360 | PubTator, text mining | PubMed |
| H2S as a Bridge Linking Inflammation, Oxidative Stress and Endothelial Biology: A Possible Defense in the Fight against SARS-CoV-2 Infection? | Biomedicines | 2021 | 34572292 | PubTator, text mining | PubMed |
| Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of KATP-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital. | Front Endocrinol (Lausanne) | 2021 | 34566892 | PubTator, text mining | PubMed |
| Integrative Neuroinformatics for Precision Prognostication and Personalized Therapeutics in Moderate and Severe Traumatic Brain Injury. | Front Neurol | 2021 | 34557154 | PubTator, text mining | PubMed |
| Lipoproteins as Markers for Monitoring Cancer Progression. | J Lipids | 2021 | 34552769 | PubTator, text mining | PubMed |
| Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity. | J Enzyme Inhib Med Chem | 2021 | 34551654 | PubTator, text mining | PubMed |
| Sulfonylureas for Treatment of Periodontitis-Diabetes Comorbidity-Related Complications: Killing Two Birds With One Stone. | Front Pharmacol | 2021 | 34539410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6833/papers?page=54